The Reporting on ERAS Compliance, Outcomes, and Elements Research (RECOvER) Checklist: A Joint Statement by the ERAS® and ERAS® USA Societies

Kevin M Elias, Alexander B Stone, Katharine McGinigle, Jo'An I Tankou, Michael J Scott, William J Fawcett, Nicolas Demartines, Dileep N Lobo, Olle Ljungqvist, Richard D Urman, ERAS® Society and ERAS® USA, Kevin Elias, Maria Adamian, Frederic Bushnell, Arman Dagal, Chad Engan, Joseph Marcotte, Katharine McGinigle, Nicollete Pauksta, Venu Pillarisetty, Jo'An Tankou, Kevin M Elias, Alexander B Stone, Katharine McGinigle, Jo'An I Tankou, Michael J Scott, William J Fawcett, Nicolas Demartines, Dileep N Lobo, Olle Ljungqvist, Richard D Urman, ERAS® Society and ERAS® USA, Kevin Elias, Maria Adamian, Frederic Bushnell, Arman Dagal, Chad Engan, Joseph Marcotte, Katharine McGinigle, Nicollete Pauksta, Venu Pillarisetty, Jo'An Tankou

Abstract

Background: Enhanced recovery after surgery (ERAS) programs are multimodal care pathways designed to minimize the physiological and psychological impact of surgery for patients. Increased compliance with ERAS guidelines is associated with improved patient outcomes across surgical types. As ERAS programs have proliferated, an unintentional effect has been significant variation in how ERAS-related studies are reported in the literature.

Methods: To improve the quality of ERAS reporting, ERAS® USA and the ERAS® Society launched an effort to create an instrument to assist authors in manuscript preparation. Criteria to include were selected by a combination of literature review and expert opinion. The final checklist was refined by group consensus.

Results: The Societies present the Reporting on ERAS Compliance, Outcomes, and Elements Research (RECOvER) Checklist. The tool contains 20 items including best practices for reporting clinical pathways, compliance auditing, and formatting guidelines.

Conclusions: The RECOvER Checklist is intended to provide a standardized framework for the reporting of ERAS-related studies. The checklist can also assist reviewers in evaluating the quality of ERAS-related manuscripts. Authors are encouraged to include the RECOvER Checklist when submitting ERAS-related studies to peer-reviewed journals.

Conflict of interest statement

MS has received honoraria from Merck, Baxter, Deltex and Cheetah Medical for lecturing and travel expenses. RU has received research funding from Medtronic, Mallinckrodt, Merck, and honorarium from 3M. DNL has received unrestricted research funding and speaker’s honoraria from Fresenius Kabi, BBraun and Baxter Healthcare for unrelated work. OL has received honoraria from Merck, Fresenius Kabi, Nutricia, Baxter and Abbot for advice or lecturing and travel expenses. OL is a shareholder of Encare AB, Sweden, an IT company involved in audit. WJF reports honoraria from Merck, Baxter, Grunethal and Smiths for lecturing and travel expenses. The remaining authors have no disclosures.

References

    1. Ljungqvist O, Scott M, Fearon KC. Enhanced recovery after surgery: a review. JAMA Surg. 2017;152:292–298. doi: 10.1001/jamasurg.2016.4952.
    1. Lau CS, Chamberlain RS. Enhanced recovery after surgery programs improve patient outcomes and recovery: a meta-analysis. World J Surg. 2017;41:899–913. doi: 10.1007/s00268-016-3807-4.
    1. Visioni A, Shah R, Gabriel E, et al. Enhanced recovery after surgery for noncolorectal surgery?: A systematic review and meta-analysis of major abdominal surgery. Ann Surg. 2018;267:57–65. doi: 10.1097/SLA.0000000000002267.
    1. Elias KM. Understanding enhanced recovery after surgery guidelines: an introductory approach. J Laparoendosc Adv Surg Tech A. 2017;27:871–875. doi: 10.1089/lap.2017.0342.
    1. Gustafsson UO, Hausel J, Thorell A, et al. Adherence to the enhanced recovery after surgery protocol and outcomes after colorectal cancer surgery. Arch Surg. 2011;146:571–577. doi: 10.1001/archsurg.2010.309.
    1. Gustafsson UO, Oppelstrup H, Thorell A, et al. Adherence to the ERAS protocol is associated with 5-year survival after colorectal cancer surgery: a retrospective cohort study. World J Surg. 2016;40:1741–1747. doi: 10.1007/s00268-016-3460-y.
    1. Simpson JC, Moonesinghe SR, Grocott MP, et al. Enhanced recovery from surgery in the UK: an audit of the enhanced recovery partnership programme 2009–2012. Br J Anaesth. 2015;115:560–568. doi: 10.1093/bja/aev105.
    1. Group EC The impact of enhanced recovery protocol compliance on elective colorectal cancer resection: results from an international registry. Ann Surg. 2015;261:1153–1159. doi: 10.1097/SLA.0000000000001029.
    1. Xiong J, Szatmary P, Huang W, et al. Enhanced recovery after surgery program in patients undergoing pancreaticoduodenectomy: a PRISMA-compliant systematic review and meta-analysis. Medicine (Baltimore) 2016;95:e3497. doi: 10.1097/MD.0000000000003497.
    1. Huang H, Ma H, Chen S. Enhanced recovery after surgery using uniportal video-assisted thoracic surgery for lung cancer: a preliminary study. Thorac Cancer. 2018;9:83–87. doi: 10.1111/1759-7714.12541.
    1. Semerjian A, Milbar N, Kates M, et al. Hospital charges and length of stay following radical cystectomy in the enhanced recovery after surgery era. Urology. 2018;111:86–91. doi: 10.1016/j.urology.2017.09.010.
    1. Nelson G, Altman AD, Nick A, et al. Guidelines for postoperative care in gynecologic/oncology surgery: enhanced recovery after surgery (ERAS(R)) Society recommendations—part II. Gynecol Oncol. 2016;140:323–332. doi: 10.1016/j.ygyno.2015.12.019.
    1. Paduraru M, Ponchietti L, Casas IM, et al. Enhanced recovery after emergency surgery: a systematic review. Bull Emerg Trauma. 2017;5:70–78.
    1. Day RW, Fielder S, Calhoun J, et al. Incomplete reporting of enhanced recovery elements and its impact on achieving quality improvement. Br J Surg. 2015;102:1594–1602. doi: 10.1002/bjs.9918.
    1. Moonesinghe SR, Grocott MPW, Bennett-Guerrero E, et al. American Society for Enhanced Recovery (ASER) and Perioperative Quality Initiative (POQI) joint consensus statement on measurement to maintain and improve quality of enhanced recovery pathways for elective colorectal surgery. Perioper Med (Lond) 2017;6:6. doi: 10.1186/s13741-017-0062-7.
    1. Rollins KE, Lobo DN. Intraoperative goal-directed fluid therapy in elective major abdominal surgery: a meta-analysis of randomized controlled trials. Ann Surg. 2016;263:465–476. doi: 10.1097/SLA.0000000000001366.
    1. Moher D, Schulz KF, Simera I, et al. Guidance for developers of health research reporting guidelines. PLoS Med. 2010;7:e1000217. doi: 10.1371/journal.pmed.1000217.
    1. Callesen T, Klarskov B, Bech K, et al. Short convalescence after inguinal herniorrhaphy with standardised recommendations: duration and reasons for delayed return to work. Eur J Surg. 1999;165:236–241. doi: 10.1080/110241599750007108.
    1. Myles PS, Shulman MA, Heritier S, et al. Validation of days at home as an outcome measure after surgery: a prospective cohort study in Australia. BMJ Open. 2017;7:e015828. doi: 10.1136/bmjopen-2017-015828.
    1. Fawcett WJ, Mythen MG, Scott MJ. Enhanced recovery: More than just reducing length of stay? Br J Anaesth. 2012;109:671–674. doi: 10.1093/bja/aes358.
    1. Petersen PB, Jorgensen CC, Kehlet H, et al. Delirium after fast-track hip and knee arthroplasty—a cohort study of 6331 elderly patients. Acta Anaesthesiol Scand. 2017;61:767–772. doi: 10.1111/aas.12932.
    1. Keller DS, Tantchou I, Flores-Gonzalez JR, et al. Predicting delayed discharge in a multimodal enhanced recovery pathway. Am J Surg. 2017;214:604–609. doi: 10.1016/j.amjsurg.2017.06.008.
    1. Dickson EL, Stockwell E, Geller MA, et al. Enhanced recovery program and length of stay after laparotomy on a gynecologic oncology service: a randomized controlled trial. Obstet Gynecol. 2017;129:355–362. doi: 10.1097/AOG.0000000000001838.
    1. Phan TD, D’Souza B, Rattray MJ, et al. A randomised controlled trial of fluid restriction compared to oesophageal Doppler-guided goal-directed fluid therapy in elective major colorectal surgery within an enhanced recovery after surgery program. Anaesth Intensive Care. 2014;42:752–760.
    1. Boutron I, Dutton S, Ravaud P, et al. Reporting and interpretation of randomized controlled trials with statistically nonsignificant results for primary outcomes. JAMA. 2010;303:2058–2064. doi: 10.1001/jama.2010.651.

Source: PubMed

スポンサーと協力者

医学的状態

薬物療法

3
購読する